2022-09-14
ESHG Pharmacogenetics Course

Topics

  • Pharmacogenetics and pharmacogenomics
  • Pharmacogenomics resources and databases
  • Clinical implementation of pharmacogenetics and pharmacogenomics
  • Individualized drug treatment
  • Drug-drug-gene interactions
  • Cancer pharmacogenomics
  • Novel biomarkers of treatment response
  • Novel diagnostic and prognostic biomarkers
  • NGS for pharmacogenomics

Programme at first glance (PDF)

Programme (PDF)


Confirmed speakers

  • Nada Božina, Clinical Institute of Laboratory Diagnosis, Zagreb University School of Medicine, Croatia
  • Erika Cecchin, CRO Aviano, Italy
  • Vita Dolžan, Faculty of Medicine, University of Ljubljana, Slovenia
  • Raffaella Franca, Department of Medical, Surgical and Health Sciences, University of Trieste, Italy
  • Vladimir Gašić, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia
  • Katja Goričar, Faculty of Medicine, University of Ljubljana, Slovenia
  • Magnus Ingelman-Sundberg, Karolinska Institute, Stockholm, Sweden
  • Nikola Kotur, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia
  • Metka Lenassi / Marija Holcar, Faculty of Medicine, University of Ljubljana, Slovenia
  • John McDermott, Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, United Kingdom
  • William Newman, Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust, United Kingdom
  • Sonja Pavlović, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia
  • Sir Munir Pirmohamed, MRC Centre for Drug Safety Science and Wolfson Centre for Personalised Medicine and Institute of Translational Medicine, University of Liverpool, United Kingdom
  • Cristina Rodriguez-Antona, Spanish National Cancer Research Centre, Madrid, Spain
  • Ron van Schaik, Erasmus MC, Rotterdam, The Netherlands
  • Biljana Stanković, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia
  • Julia C. Stingl, Institute of Clinical Pharmacology, Aachen, Germany
  • Gabriele Stocco, University of Trieste, Italy
  • Nataša Toplak, Omega d.o.o., Slovenia
  • Branka Zukić, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia
2006 - Univerza v Ljubljani, Medicinska fakulteta, Institut za biokemijo.